Cardiol Therapeutics Inc. (NASDAQ:CRDL – Free Report) – Equities research analysts at Leede Jones Gab upped their FY2024 earnings per share estimates for Cardiol Therapeutics in a report issued on Monday, March 25th. Leede Jones Gab analyst D. Loe now forecasts that the company will earn ($0.31) per share for the year, up from their […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) and Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends. Profitability This table compares Adaptive Biotechnologies and […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) and Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation. Profitability This table compares Adaptive Biotechnologies and […]
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) CEO David Elsley joined Steve Darling from Proactive with news the company has unveiled highly promising study.